Latest Commercialization News

Neurizon Therapeutics has been granted a pivotal US patent for its lead drug candidate NUZ-001, extending protection until 2039 and enhancing its commercial and clinical positioning in neurodegenerative disease treatment.

A new peer-reviewed study highlights Cynata Therapeutics’ Cymerus™ iPSC-derived MSCs as superior to traditional donor tissue-derived MSCs in potency, consistency, and regenerative potential.

Canyon Resources announces Peter Secker as new CEO, signaling a strategic shift as the company advances its Minim Martap bauxite project toward production.

Audeara Limited has landed a significant US$917,000 follow-up purchase order from a global music instrument manufacturer, reinforcing the commercial viability of its hearing technology and expanding its licensing footprint.

Sunrise Energy Metals has updated its Syerston Scandium Project Mineral Resource Estimate, confirming a substantial global resource and planning a targeted drilling campaign to expand high-grade zones. The company is advancing product development with key partners amid growing demand for scandium in strategic sectors.

Green Technology Metals (GT1) is progressing its lithium conversion facility in Ontario, with pilot testing underway and a pre-feasibility study due in April 2025. The project aims to establish Ontario's first vertically integrated lithium concentrates and chemicals business, leveraging a strategic partnership with EcoPro.

Altair Minerals unveils its strategic exploration projects in Peru's prolific Venatica copper belt and Australia's Olympic Domain, aiming to unlock major copper-gold deposits with a seasoned technical team at the helm.

SportsHero has secured a two-year deal with Indonesia’s third-largest telco, XL Axiata, to market its iGV Family Game Pass, leveraging Direct Carrier Billing to tap into 8.3 million PC gamers. This partnership positions SportsHero at the forefront of Southeast Asia’s rapidly growing esports sector.

Biome Australia has partnered with the Food and Beverage Accelerator (FaBA) to jointly develop its promising BMB18 probiotic strain, leveraging $50 million in Australian government funding while retaining full IP ownership.

Bio-Gene Technology Limited has secured A$3 million in U.S. Department of Defense grants to accelerate development of its two nature-derived insecticides, Flavocide and Qcide, targeting both military and civilian markets.

AXP Energy has secured $1.25 million through a share placement to accelerate its modular data centre rollout powered by stranded natural gas in Colorado. This capital injection aims to support the company’s pioneering gas-to-power operations tied to Bitcoin mining and other high-performance computing applications.

Wellnex Life has secured Therapeutic Goods Administration approval for its Liquid Paracetamol plus Caffeine Soft Gel, marking its fourth market authorisation and opening new revenue avenues.